Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to equity ratio is 0.00 as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
0.00
DEBT TO EQUITY RATIO AVG 3Y
0.00
DEBT TO EQUITY RATIO AVG 5Y
0.00
DEBT TO EQUITY RATIO AVG 10Y
0.00
DEBT TO EQUITY RATIO AVG 15Y
0.00
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.15
median of 406 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$25.48M
Debt to Equity Ratio
0.17
TTM Avg
1.46
3Y Avg
1.37
5Y Avg
1.15
Market Cap
$21.90M
Debt to Equity Ratio
0.51
TTM Avg
0.86
3Y Avg
0.77
5Y Avg
0.62
Market Cap
$27.31M
Debt to Equity Ratio
0.10
TTM Avg
0.05
3Y Avg
0.16
5Y Avg
0.16
Market Cap
$20.93M
Debt to Equity Ratio
0.41
TTM Avg
0.03
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$28.43M
Debt to Equity Ratio
0.23
TTM Avg
0.18
3Y Avg
0.17
5Y Avg
0.13
Market Cap
$18.82M
Debt to Equity Ratio
0.77
TTM Avg
0.78
3Y Avg
0.55
5Y Avg
1.68
Market Cap
$18.77M
Debt to Equity Ratio
N/A
TTM Avg
0.00
3Y Avg
0.02
5Y Avg
0.01
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | 0.00 | 0.00 | 0.00 | 0.00 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | 0.17 | 1.46 | 1.37 | 1.15 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | 0.51 | 0.86 | 0.77 | 0.62 |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | 0.10 | 0.05 | 0.16 | 0.16 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | 0.41 | 0.03 | 0.02 | 0.02 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 0.23 | 0.18 | 0.17 | 0.13 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | 0.77 | 0.78 | 0.55 | 1.68 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | 0.00 | 0.02 | 0.01 |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00 | 0.00 | 0.00 | 0.00 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01 | 0.00 | 0.00 | 0.00 |
Debt/Equity
0.00
Current Ratio
5.69
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.00 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.01 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.01 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.01 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.01 |
| 2015-03-31 | 0.01 |
| 2014-12-31 | 0.01 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.07 |
| 2012-06-30 | -0.45 |
| 2012-03-31 | 0.43 |
| 2011-12-31 | 0.64 |
| 2011-09-30 | 0.37 |
| 2011-06-30 | 0.00 |
| 2011-03-31 | 0.00 |
| 2010-12-31 | -0.22 |
| 2010-09-30 | -0.20 |
| 2010-06-30 | -0.09 |
| 2009-09-30 | 0.00 |
